Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergan, Inc.
Allergan completes note offerings, redeems convertible notes due 2022
May 8th, 2006
Allergan, Inc., (AGN) has completed its previously announced concurrent private placements of $750 million aggregate principal amount of 1.50% convertible senior notes due 2026 and $800 million aggregate principal amount of 5.75% senior notes due 2016. Allergan also announced that it will redeem the entire outstanding principal amount of its Zero Coupon Senior Convertible Notes due 2022 on May 15, 2006. The notice of redemption was sent to the holders of the Zero Coupon Senior Convertible Notes due 2022 on or about April 12, 2006. Allergan develops and commercializes products in the ophthalmology, neurosciences, medical...
Source: Biotech Week (2006-05-08)
|
